Arrowhead pharmaceuticals, inc. (ARWR)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Dec'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)

-19,835

-2,673

11,704

20,335

23,896

12,037

-10,761

-15,606

-14,884

-13,198

-10,731

-5,519

-6,042

-12,086

-22,221

-19,420

-20,815

-19,264

-24,743

-15,936

-28,686

-22,575

-22,430

-11,626

-13,982

-10,685

-4,780

Net loss attributable to non-controlling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

2

-40

-57

-166

NET LOSS ATTRIBUTABLE TO ARROWHEAD

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-22,430

-11,628

-13,942

-10,628

-4,614

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

Realized and unrealized (gain) loss on investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Charge for bad debt allowance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

(Gain) loss on purchase of Roche Madison

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

(Gain) loss from sale of subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

(Gain) loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45

-26

0

0

-5

-53

18

Stock issued for professional services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Change in value of derivatives

-

-

-

-

-

-

0

0

-18

450

-629

63

-27

1,483

-534

-113

369

-23

422

-104

168

2,382

-321

758

-2,951

-3,519

44

Contingent consideration - fair value adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Noncash impairment expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchased in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stock-based compensation

12,971

4,491

5,116

1,957

2,601

2,717

2,636

2,268

1,456

2,092

2,009

1,713

1,744

2,424

4,047

2,750

2,416

2,380

3,526

2,486

2,205

2,014

1,937

2,038

1,198

521

395

Depreciation and amortization

1,371

1,259

1,082

1,003

1,175

1,177

1,228

1,176

1,153

1,141

1,154

1,162

1,187

1,185

843

818

803

794

855

741

449

290

270

276

395

403

449

Amortization/(accretion) of note premiums

-241

-177

-386

-352

-486

156

199

-236

-238

-107

-

-

-

-

-30

-21

-287

108

-2,055

276

320

347

377

146

240

28

0

Gain on sale of stock in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

2

-40

-57

-166

Equity in income (loss) of unconsolidated affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-63

Changes in operating assets and liabilities:
Accounts receivable

-79

683

-1,382

-11,378

10,253

2,841

312

-1

-133

82

-869

356

520

-15

-

-

-1,029

1,054

-

-

-

136

0

0

-86

11

105

Prepaid expenses and other current assets

1,331

-1,377

1,317

952

1,319

120

537

369

-1,254

29

362

-652

-1,497

-1,027

133

270

126

490

-

-

-

-

-

-

-

-

-

Deferred revenue

-20,859

-28,770

-15,136

-22,681

-37,474

158,096

-942

-621

-310

-3,394

-8,638

-8,511

-8,345

25,652

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-93

611

0

0

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,874

-

-

-

74

-157

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

Accounts payable

1,216

4,551

3,019

568

125

1,130

640

355

-3,896

1,630

843

635

-340

-4,648

1,641

-1,597

2,253

257

169

-74

-1,013

3,415

421

-321

1,922

-610

-68

Accrued expenses

-1,210

-4,213

5,927

-1,136

1,149

-3,489

5,669

-1,734

-368

-2,550

4,936

78

-3,564

-1,850

3,856

-662

-120

-3,945

6,590

-712

-116

-1,325

3,018

184

218

56

111

Other

-227

953

1,642

-297

25

-265

-102

-115

-240

43

-9

-125

96

-235

106

-166

147

42

-72

-2

35

-0

98

209

8

-222

14

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

-27,583

-23,530

13,809

10,526

-19,586

168,284

-2,680

-14,409

-15,443

-14,690

-9,203

-10,409

-14,326

10,000

-10,181

-18,350

-14,747

-21,148

-12,020

-13,117

-16,369

-24,200

-10,919

-9,776

-7,697

-7,022

-3,837

Purchases of property and equipment

3,609

4,319

7,830

3,223

209

737

709

198

378

135

107

1,157

1,356

5,296

2,712

647

94

406

834

283

297

554

465

644

491

116

9

Proceeds from sale of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

0

121

Purchases of marketable securities

-

-

0

0

20,995

69,271

4,908

42,156

0

5,018

-

-

-

-

-

-

-

-

-

-

-

-

0

0

27,290

19,075

0

Proceeds from sale of marketable securities

6,002

13,600

24,660

17,622

9,987

2,252

8,865

13,500

17,194

6,510

-

-

-

-

1,000

10,108

3,200

3,000

6,679

7,260

9,096

3,054

5,000

1,580

964

4,045

0

Other investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Cash paid for acquisitions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3,000

0

7,000

-

-

-

-

-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

-178,129

9,280

16,829

14,398

-11,217

-67,756

3,247

-28,854

16,815

1,356

-4,218

-12,926

-26,202

-5,296

-1,712

9,460

3,105

2,593

5,844

3,976

8,798

-4,499

4,544

936

-26,817

-15,145

111

CASH FLOWS FROM FINANCING ACTIVITIES:
Cash transferred in acquisitions/divestitures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchase of MASA Energy, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Minority equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash paid for interest in Insert

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash obtained from interest in Insert

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment for patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Principal payments on notes payable

-

-

0

0

0

2,415

53

52

-95

197

100

0

49

47

54

54

54

54

53

53

3

103

-31

52

149

54

53

Proceeds from the exercises of stock options

1,330

3,001

-

-

2,670

1,004

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of taxes for net share settled restricted stock unit issuances

-

-

-

-

-

-

-

-

-

-

21

0

0

417

0

0

193

440

-

-

-

-

-

-

-

-

-

Proceeds from the exercises of warrants and stock options

-

-

-

-

-

-

1,624

1,506

275

224

-

-

-

-

-

-

-

-

190

0

30

283

504

4,394

7,979

0

-

Proceeds from sale of stock in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from the issuance of common stock

2

250,476

0

0

0

60,521

-

-

-

-

0

-272

191

12,500

-

-

-

-

-

-

-

-

-0

0

109,820

62,821

3,332

Proceeds from issuance of Calando debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

1,332

253,478

1,833

2,767

2,670

59,111

1,571

1,454

56,901

26

-122

0

142

12,035

53,643

2,205

-222

-494

136

-53

26

180

535

4,342

117,649

62,766

3,279

NET INCREASE (DECREASE) IN CASH

-204,381

239,228

32,472

27,692

-28,133

159,639

2,137

-41,809

58,273

-13,307

-13,544

-23,335

-40,386

16,739

41,749

-6,684

-11,864

-19,049

-6,038

-9,194

-7,543

-28,519

-5,839

-4,498

83,134

40,598

-446

Cash flows from discontinued operations:
Operating cash flows

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

Investing cash flows

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Financing cash flows

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash used in discontinued operations:

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

Supplementary disclosures:
Interest paid

-

-

0

0

0

27

41

42

43

44

45

46

47

48

2

3

2

3

3

3

3

3

4

4

7

9

11

Property and Equipment expenditures included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

1,041

-

-

-

-

-

-

-

-

-

-

-

-

-

Income Taxes Paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0